[b]Neuropharmacological potential of hono... - Cure Parkinson's

Cure Parkinson's

25,550 members26,870 posts

[b]Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species[/b]

Bolt_Upright profile image
5 Replies

I did not understand all of this, but I am going to keep taking my 400 mg of Swanson Magnolia Extract every night. Been taking it for well over a year.

Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint 2023 cmjournal.biomedcentral.com...

"Concluding remarks and future directions

Even while technological advances have significantly sped up the process of assessing phytochemicals, there is still a lot of work to be done until we have a more definite understanding of the neurotherapeutic advantages of herbal medications. As a consequence of our findings and other studies' findings, we have concluded that honokiol's ability to change several signaling pathways makes it potentially useful as a medicine for treating NDs. Despite the limitations of the ongoing clinical study, honokiol is showing great potential as a potential treatment for a wide range of NDs, including AD, PD, cerebral ischemia, anxiety, depression, spinal cord, and others. Even though a significant amount of preclinical research studies have been carried out to evaluate the neurotherapeutic potential of honokiol, the compound's clinical potential has not yet been used. There is a need for more research to improve the bioavailability of honokiol and for clinical studies to be carried out to evaluate the therapeutic efficacy of these compounds."

Written by
Bolt_Upright profile image
Bolt_Upright
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Gioc profile image
Gioc

Great choice, does it work?

Quote from your link :

Parkinson’s disease (PD)

Neuroinflammation is a complex process that plays a role in various complex conditions affecting the brain, including ischemia injury and neurodegenerative diseases such as multiple sclerosis and PD [49]. Atrophy of projection fibers from the substantia nigra pars compacta to the striatum results from the progressive death of substantia nigra pars compacta dopaminergic (DA) neurons, the most frequent movement state in adults. Activation of glial cells, such as astrocytes and microglia, is a pivotal biological process in neuroinflammation. Astrocytes and microglia undergo substantial structural changes during inflammation, followed by increased production of essential immunomodulatory cytokines [50, 51]. Consequently, astrocytes and microglia, under conditions of inflammatory stress, can produce several cytokines that promote inflammation. These cytokines include IL-6, TNF-α, and IL-1β [52]. Other transcription factors, such as the well-known regulator NF-kB and Krüppel-like factor 4 (KLF4), are involved in similar regulatory pathways that regulate the expression of pro and anti-inflammatory cytokines. Indeed, in addition to its actions in maintaining stem cells, KLF4 was associated with the overexpression of IL-10 and iNOS in macrophages and IL-6 in dendritic cells [53]. Endothelial cells and microglia-like cells belonging to the immune system may benefit from the role that KLF4 plays in regulating pro-inflammatory mediators [54].

Many PPARγ agonists have been shown to provide neuroprotective benefits in both in vitro and in vivo models. Dozens of different animal models of PD have revealed that PPARγ activation reduces levels of OS and inflammation, improves mitochondrial function, reduces glial activation, slows the rate of nigral dopaminergic neuron loss, and increases striatal dopamine levels (Fig. 5) [55, 56]. These outcomes conclude that PPARγ may be a therapeutically productive target for treating PD. So, therapeutic interventions targeting PPARγ in people with PD may effectively reduce the severity of disease symptoms and halt the long process of neurodegeneration [57, 58]…”

Vitamin b3 na does the same thing:

So, therapeutic interventions targeting PPARγ in people with PD may effectively reduce the severity of disease symptoms and halt the long process of neurodegeneration”.

Do your research.🤗

Bolt_Upright profile image
Bolt_Upright in reply to Gioc

I take both!

LindaP50 profile image
LindaP50

How does this work for you, the benefits?

Bolt_Upright profile image
Bolt_Upright in reply to LindaP50

I don't know. I have not been diagnosed with PD. I have REM Sleep Behavior Disorder, which doctors say is prodromal PD. When I was diagnosed in April 2021 I also had a sore left shoulder and left leg, face dandruff, get dizzy when I stand, and have random involuntary movements. I can say "had" to most of those conditions: My RBD is now very mild and rare. Random involuntary movements are rare. I don't get dizzy when I stand. My face dandruff gone. My sore shoulder is still sore, but not as bad. I have gone back to using a mouse left handed after a year of going right handed. I should also add: I do a lot of things besides PEA.

I also used to have an occasional tremor in my left hand. Maybe every week or two. Like when I was holding a plate, or washing silverware. And even when it did not tremor, the hand felt like it might tremor (if that makes sense). It was very minor. That seems to be gone (please don't jinx myself, please don't jinx myself, please don't jinx myself).

I do a lot of thingz : rbd-pd-protocols.blogspot.c...

And I have a high school degree, so no expert advice here.

Likii profile image
Likii

Check out Relora which adds Phellodendron to Magnolia Officinalis.

Phellodendron has been found comparable in effect to PD drug selegiline. Sorry, too lazy to post the link but interested people can find it at PubMed.

You may also like...

Clinical trial suggests Parkinson's drug is safe in humans

A new study finds an experimental drug that is significant for PD treatment \\" A large team of...

A New Rabbit Hole: Magnolia Bark Extract

3221833498X \\"The aim of this study was to investigate the therapeutic abilities of honokiol on...

B Vitamins and the Brain: Mechanisms, Dose and Efficacy

to study the effects of supplementing with the full range of B vitamins at higher doses. Research on

BREAKTHROUGH! Parkinson's Progression HALTED by Inhibiting Enzyme!

a new therapeutic avenue that could slow or even prevent Parkinson’s progression. The study...

Patients with Parkinson’s disease (PD) report a strong craving for sweets

\\"Lately, studies have shown that patients with Parkinson’s disease (PD) report a strong...